Comparison of screening outcome measures in the third round of the pilot with those in the Nottingham trial
| Population | Uptake (%) | Positive outcome (%) | Cancer detection rate per 1000 | Neoplasia detection rate per 1000 | PPV cancer (%) | PPV neoplasia (%) | |
| Third round (restricted to people who responded in the first and second rounds) | |||||||
| Pilot | 25 728 | 90.6 | 1.41 | 0.94 | 5.15 | 6.69 | 36.47 |
| Nottingham | 11 892 | 91.6 | 1.04 | 1.10 | 4.50 | 10.62 | 43.36 |
| Third round (restricted to people whose test was negative in the first and second rounds) | |||||||
| Pilot | 25 030 | 91.7 | 1.26 | 0.96 | 4.88 | 7.61 | 38.75 |
| Nottingham | 11 798 | 91.7 | 0.95 | 1.11 | 4.25 | 11.65 | 44.66 |
PPV, positive predictive value.